Mapi Posters

2012. ISPOR Annual International Meeting – The Cost- Effectiveness of Telaprevir (TVR) in Combination with Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1 (G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of IL-28B Subgroup

Curtis S, Cure S, Bianic F, Gavart S, Dearden L, Fleischmann J, Ouwens M, Lee S. The Cost- Effectiveness of Telaprevir (TVR) in Combination with Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1 (G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of IL-28B Subgroup. Value Health. 2012 Jun;15(4):A244-A245. Presented at: ISPOR 17th Annual International Meeting; June 6, 2012; Washington DC, USA.